Nevro Corp. NVRO 深 滬
等待開盤 09-20 09:30:00 美东时间
5.85
+0.030
+0.52%
華盛通- 最 高6.11
- 今 開6.11
- 成交量 41.47万股
- 最 低 5.75
- 昨 收 5.82
- 總市值 2.12亿
- 52周最高 22.64
- 市盈率 靜 --
- 換手率 1.15%
- 52周最低 4.382
- 委 比 77.78%
- 總股本 3620.55万
- 歷史最高 188.14
- 量 比 0.77
- 振 幅 6.19%
- 歷史最低 4.382
- 每 手 1
- 風險率 4.79%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多EnviroGold Global Welcomes New COO for Sustainable Growth
EnviroGold Global Limited (TSE:NVRO) has released an update. EnviroGold Global ...
09-18 01:37
EnviroGold Boosts Team and Technology Capabilities
EnviroGold Global Limited (TSE:NVRO) has released an update. EnviroGold Global ...
09-06 00:10
Nevro to Present at Wells Fargo 2024 Healthcare Conference
REDWOOD CITY, Calif., Aug. 28, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of c...
08-29 04:15
Stryker to buy pain therapy developer Vertos Medical
MedTech giant Stryker (NYSE:SYK) announced Thursday an agreement to acquire Vertos Medical, a privately held pain therapy developer headquartered in Aliso Viejo, California. Founded in 2005, Vertos of...
08-23 02:23
EnviroGold Accelerates Plant Commissioning and Expands Team
EnviroGold Global Limited (TSE:NVRO) has released an update. EnviroGold Global ...
08-22 03:07
Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08
REDWOOD CITY, Calif., Aug. 14, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), ...
08-15 04:30
J&J makes headway in settling talc baby powder litigation: reports
Johnson & Johnson (NYSE:JNJ) has reportedly made headway in its long-running battle to settle thousands of lawsuits filed over the safety of its talc-based baby powder. According to a Bloomberg report...
08-13 05:01
Stryker to acquire care.ai to expand healthcare IT portfolio
In a bid to accelerate its healthcare IT and digital vision, Stryker (NYSE:SYK) has agreed to acquire care.ai, a privately held company specializing in delivering AI-assisted virtual care workflows, s...
08-12 20:13
Citi upgrades Nevro to neutral following sell-off
Citi has upgraded Nevro (NYSE:NVRO) to neutral, citing the recent sell-off in shares following the company’s revised guidance. The investment bank noted that Nevro shares have fallen around 74% year-t...
08-10 04:51
